- Home
- SERA vs SOPH Comparison
SERA vs SOPH Comparison
Compare SERA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- SOPH
- Stock Information
- Founded
- SERA 2008
- SOPH 2011
- Country
- SERA United States
- SOPH Switzerland
- Employees
- SERA N/A
- SOPH N/A
- Industry
- SERA Precision Instruments
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SERA Health Care
- SOPH Health Care
- Exchange
- SERA Nasdaq
- SOPH Nasdaq
- Market Cap
- SERA 258.3M
- SOPH 247.0M
- IPO Year
- SERA 2021
- SOPH 2021
- Fundamental
- Price
- SERA $7.00
- SOPH $3.51
- Analyst Decision
- SERA
- SOPH Strong Buy
- Analyst Count
- SERA 0
- SOPH 3
- Target Price
- SERA N/A
- SOPH $7.00
- AVG Volume (30 Days)
- SERA 137.7K
- SOPH 28.6K
- Earning Date
- SERA 11-06-2024
- SOPH 11-05-2024
- Dividend Yield
- SERA N/A
- SOPH N/A
- EPS Growth
- SERA N/A
- SOPH N/A
- EPS
- SERA N/A
- SOPH N/A
- Revenue
- SERA $107,000.00
- SOPH $64,938,000.00
- Revenue This Year
- SERA N/A
- SOPH $7.70
- Revenue Next Year
- SERA $2,020.00
- SOPH $20.61
- P/E Ratio
- SERA N/A
- SOPH N/A
- Revenue Growth
- SERA N/A
- SOPH 20.14
- 52 Week Low
- SERA $1.56
- SOPH $2.70
- 52 Week High
- SERA $12.36
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- SERA 46.83
- SOPH 45.63
- Support Level
- SERA $6.25
- SOPH $3.03
- Resistance Level
- SERA $7.27
- SOPH $3.50
- Average True Range (ATR)
- SERA 0.52
- SOPH 0.23
- MACD
- SERA -0.10
- SOPH -0.02
- Stochastic Oscillator
- SERA 38.66
- SOPH 44.86
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.